CXCL12 and B-cell chronic lymphocytic leukemia: Moreover, the inhibition exerted by both preparations at 10 mg/mL on CLL cell activation seems not to be a general effect but rather specific to particular signalling pathways, given that the inhibition was not observed on CXCL12 or CpG-activated CLL cells (see Supplementary Fig. S6 online).